CKX Lands Q1 EPS $0.03 Down From $0.06 YoY, Sales $170.660K Down From $348.184K YoY
CryoPort (CYRX) Gets a Hold from Morgan Stanley
Cryoport and TMRW Life Sciences partner for specimen management and transport
CryoPort (CYRX) Gets a Hold from Leerink Partners
CryoPort’s Revised Guidance and Volatility Outlook Prompt Hold Rating
CryoPort Analyst Report: Hold Rating Justified by Growth Challenges and Operational Hurdles
Morgan Stanley Remains a Hold on CryoPort (CYRX)
CryoPort: A Buy Rating with Long-Term Value Potential Despite Near-Term Challenges
CKX Lands Shares Resume Trading; Up 61%
Sign up for free to unlock this feature.
Creating your account...
Your account has been created. Redirecting...
Loading...
This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.
